Prækliniske data afslører ingen speciel fare for mennesker på baggrund af konventionelle studier af safety farmakologi, repeated dose toksicitet, carcinogenicitet eller genotoksicitet.
Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, carcinogenicity or genotoxicity.